We are live on ! Find out more
Ken Fisher

Ken Fisher Fisher Asset Management

AUM $295B
1-Year Est. Return 31.6%
 

Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.

This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+31.6%
3 Year Est. Return
+103.15%
5 Year Est. Return
+125.52%
10 Year Est. Return
+433.44%
AUM
$99B
AUM Growth
+$7.83B
Cap. Flow
-$1.81B
Cap. Flow %
-1.83%
Top 10 Hldgs %
27.54%
Holding
981
New
78
Increased
256
Reduced
457
Closed
83

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$171M
2
PBR icon
Petrobras
PBR
+$64.7M
3
VALE icon
Vale
VALE
+$62.7M
4
WMGI
Wright Medical Group Inc
WMGI
+$61.9M
5
HDB icon
HDFC Bank
HDB
+$57.2M

Sector Composition

Rank Sector Weight
1 Technology 20.83%
2 Financials 13.08%
3 Healthcare 10.74%
4 Consumer Discretionary 8.75%
5 Energy 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUJ icon
576
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$637M
$592K ﹤0.01%
+41,263
New +$587K
SPMB icon
577
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.95B
$591K ﹤0.01%
22,642
-2,408
-10% -$63.1K
ACN icon
578
Accenture
ACN
$102B
$586K ﹤0.01%
2,781
+620
+29% +$121K
PTEN icon
579
Patterson-UTI
PTEN
$3.98B
$562K ﹤0.01%
53,485
-757,362
-93% -$6.85M
SYK icon
580
Stryker
SYK
$125B
$560K ﹤0.01%
2,666
-73
-3% -$15.2K
TMO icon
581
Thermo Fisher Scientific
TMO
$213B
$553K ﹤0.01%
1,702
+123
+8% +$37.3K
CLDT
582
Chatham Lodging
CLDT
$622M
$549K ﹤0.01%
29,918
DUK icon
583
Duke Energy
DUK
$97.8B
$547K ﹤0.01%
5,999
+914
+18% +$83.8K
FDS icon
584
Factset
FDS
$9.36B
$540K ﹤0.01%
2,011
-16
-0.8% -$4.11K
ACC
585
DELISTED
American Campus Communities, Inc.
ACC
$537K ﹤0.01%
11,419
-1,367
-11% -$65.4K
PGNX
586
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$535K ﹤0.01%
105,125
SU icon
587
Suncor Energy
SU
$79.4B
$526K ﹤0.01%
16,037
-17,602
-52% -$549K
APH icon
588
Amphenol
APH
$198B
$525K ﹤0.01%
19,408
-124
-0.6% -$3.17K
RNST icon
589
Renasant Corp
RNST
$3.98B
$521K ﹤0.01%
14,718
SHYG icon
590
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
$510K ﹤0.01%
10,989
+44
+0.4% +$2.03K
BND icon
591
Vanguard Total Bond Market
BND
$157B
$502K ﹤0.01%
5,984
+2,573
+75% +$216K
DAL icon
592
Delta Air Lines
DAL
$57.5B
$501K ﹤0.01%
8,560
+3,720
+77% +$209K
EPAM icon
593
EPAM Systems
EPAM
$5.51B
$500K ﹤0.01%
2,357
-31
-1% -$6.1K
RES icon
594
RPC Inc
RES
$1.24B
$499K ﹤0.01%
95,278
-796,205
-89% -$3.57M
VRSN icon
595
VeriSign
VRSN
$26.2B
$496K ﹤0.01%
2,575
+24
+0.9% +$4.51K
ACHC icon
596
Acadia Healthcare
ACHC
$2.76B
$494K ﹤0.01%
14,880
-133,323
-90% -$4.18M
AA icon
597
Alcoa
AA
$11.9B
$487K ﹤0.01%
22,623
-124,385
-85% -$2.57M
SPDW icon
598
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
$486K ﹤0.01%
+15,500
New +$472K
IGIB icon
599
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$484K ﹤0.01%
8,341
-1,050
-11% -$60.8K
VYM icon
600
Vanguard High Dividend Yield ETF
VYM
$80.9B
$479K ﹤0.01%
5,111
+2,701
+112% +$245K

Similar funds

Ken Fisher's Q4 2019 Portfolio in Review

As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
  • Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
  • Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
  • Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
  • Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
  • Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
  • Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.

Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.